smartbax GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
smartbax GmbH - overview
Established
2021
Location
Munich, -, Germany
Primary Industry
Biotechnology
About
Founded in 2021, and based in Germany, smartbax GmbH dba smartbax, is a biotech company that targets multiple unexplored areas to effectively treat bacterial infections. The company focuses on the development of a next-generation of antibiotics in response to the growing prevalence of multidrug-resistant bacteria and targets drug-resistant pathogens like methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. This approach empowers patients to combat multiple drug-resistant bacteria effectively. Additionally, the company aims to bolster its scientific team to advance the development of its research platforms.
Current Investors
Boehringer Ingelheim Venture, High-Tech Gruenderfonds, Bayern Kapital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.smartbax.de
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.